Sequenom (SQNM) volatility elevated at 128 into SEC inquiry
Down)
Sequenom (Nasdaq: SQNM) : Sequenom is recently down 24c to $3.67 in pre-open trading. The Securities and Exchange Commission (SEC) has initiated an investigation relating to its SEQureDX Down Syndrome test. Revalidation studies of the Down Syndrome test are expected in late 2009. SQNM July 4 straddle is priced at $75, August 4 straddle is pried at $1.55, September 4 straddle is priced at $2.15; December 4 straddle is priced at $2.85. SQNM over all option implied volatility of 128 is above its six-month average of 111, according to Track Data, suggesting larger price movement. Paul Foster
You May Also Be Interested In
- Savient Pharma (SVNT) Moves Higher with Volatility; Bumps Up Against Key Resistance Point
- DryShips (DRYS) Trading Higher on Volatility, New Analyst Coverage
- Corinthian Colleges (COCO) Bounces Off Intraday Lows into Close
Create E-mail Alert Related Categories
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
